Tags

Type your tag names separated by a space and hit enter

Nutrition, phosphorus, and keto-analogues in hemodialysis patients: a Chinese perspective.
J Ren Nutr. 2013 May; 23(3):214-7.JR

Abstract

The optimal dietary protein requirements in maintenance hemodialysis (HD) patients and how to balance the treatments between the nutritional intervention and other approaches are still controversies among nephrologists. In China, excessive dietary intake, low dose of dialysis, and lack of non-calcium-containing phosphorus binders are the main causes of hyperphosphatemia among HD patients. If the daily protein intake reached the recommended dose of 1.2 g/kg body weight per the Kidney Disease Outcomes Quality Initiative guidelines, the net accumulation of phosphorus in patients receiving conventional thrice-weekly low-flux HD may reach 1550 mg per week on the basis of our studies on the assessment of phosphorus removal by HD and residual renal function. In fact, a relatively low-protein diet supplemented with keto-analogues could maintain the stable nutritional status in dialysis patients and provide additional beneficial effects. An individualized nutritional intervention is worth trying to treat hyperphosphatemia in HD patients.

Authors+Show Affiliations

Division of Nephrology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, People's Republic of China. chenjing1998@fudan.edu.cn

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

23611550

Citation

Chen, Jing. "Nutrition, Phosphorus, and Keto-analogues in Hemodialysis Patients: a Chinese Perspective." Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation, vol. 23, no. 3, 2013, pp. 214-7.
Chen J. Nutrition, phosphorus, and keto-analogues in hemodialysis patients: a Chinese perspective. J Ren Nutr. 2013;23(3):214-7.
Chen, J. (2013). Nutrition, phosphorus, and keto-analogues in hemodialysis patients: a Chinese perspective. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation, 23(3), 214-7. https://doi.org/10.1053/j.jrn.2013.01.020
Chen J. Nutrition, Phosphorus, and Keto-analogues in Hemodialysis Patients: a Chinese Perspective. J Ren Nutr. 2013;23(3):214-7. PubMed PMID: 23611550.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Nutrition, phosphorus, and keto-analogues in hemodialysis patients: a Chinese perspective. A1 - Chen,Jing, PY - 2012/12/30/received PY - 2013/01/17/accepted PY - 2013/4/25/entrez PY - 2013/4/25/pubmed PY - 2014/1/5/medline SP - 214 EP - 7 JF - Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation JO - J Ren Nutr VL - 23 IS - 3 N2 - The optimal dietary protein requirements in maintenance hemodialysis (HD) patients and how to balance the treatments between the nutritional intervention and other approaches are still controversies among nephrologists. In China, excessive dietary intake, low dose of dialysis, and lack of non-calcium-containing phosphorus binders are the main causes of hyperphosphatemia among HD patients. If the daily protein intake reached the recommended dose of 1.2 g/kg body weight per the Kidney Disease Outcomes Quality Initiative guidelines, the net accumulation of phosphorus in patients receiving conventional thrice-weekly low-flux HD may reach 1550 mg per week on the basis of our studies on the assessment of phosphorus removal by HD and residual renal function. In fact, a relatively low-protein diet supplemented with keto-analogues could maintain the stable nutritional status in dialysis patients and provide additional beneficial effects. An individualized nutritional intervention is worth trying to treat hyperphosphatemia in HD patients. SN - 1532-8503 UR - https://www.unboundmedicine.com/medline/citation/23611550/Nutrition_phosphorus_and_keto_analogues_in_hemodialysis_patients:_a_Chinese_perspective_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1051-2276(13)00046-0 DB - PRIME DP - Unbound Medicine ER -